Nanomix Corporation (NNMX)
OTCMKTS: NNMX · Delayed Price · USD
0.0001
0.00 (0.00%)
Dec 29, 2023, 1:00 AM EDT - Market open

Company Description

Nanomix Corporation develops and commercializes mobile point-of-care diagnostic system that is used in performing a range of in vitro diagnostic tests in various environments.

Its products are designed to enhance healthcare delivery by bringing diagnostic information to the point of initial patient interaction, whether in the hospital or in settings, such as nursing facilities, elderly homes, urgent care centers, airports, schools, and others.

The company is also developing a pipeline of other tests designed to enhance patient outcomes by making diagnostic information available.

Nanomix Corporation was founded in 2000 and is headquartered in San Leandro, California.

Nanomix Corporation
Country MA
Founded 2000
Industry Medical Devices
Sector Healthcare
Employees 30
CEO David Gerald Ludvigson

Contact Details

Address:
354 Merrimack Street, #4
Lawrence, Massachusetts 01843
United States
Phone (603) 935-9799
Website bostonti.com

Stock Details

Ticker Symbol NNMX
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001473579
CUSIP Number 63008H201
ISIN Number US63008H2013
Employer ID 27-0801073
SIC Code 2834

Key Executives

Name Position
Garrett P. Gruener Founder and Executive Chairman
David Gerald Ludvigson Interim Chief Executive Officer, President, Secretary and Director
Vidur Sahney Chief Operating Officer
Christopher R. Hetterly Chief Financial Officer
Bradley Johnson Ph.D. Chief Technology Officer

Latest SEC Filings

Date Type Title
Feb 6, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 24, 2023 8-K Current Report
May 15, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Apr 7, 2023 10-K Annual Report
Mar 31, 2023 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 10, 2023 8-K Current Report
Feb 10, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 25, 2023 8-K Current Report
Nov 14, 2022 10-Q Quarterly Report
Nov 10, 2022 8-K Current Report